Out on Wall Street, one group of stocks divides investors into either fans or critics. Penny stocks, or tickers that trade for less …
MEI Pharma announced positive preclinical data for its orally administered drug, voruciclib. Voruciclib blocks CDK9, a cyclin-dependent kinase (CDK) inhibitor and hinders growth …
Investors of MEI Pharma (MEIP) trudged off to the 4th of July celebrations in a downbeat mood. In last week’s final session, shares …
Penny stocks, they divide market watchers like no other. Some investors steer clear of these tickers going for less than $5 apiece, as …
Oppenheimer analyst Leah R. Cann initiated coverage on shares of MEI Pharma Inc (NASDAQ:MEIP) with an Outperform rating and $6.
MEI Pharma, Inc. (NASDAQ:MEIP) and Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, announced final results from a Phase …
MEI Pharma Inc (NASDAQ:MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today reported results for its fiscal year …
MEI Pharma Inc (NASDAQ:MEIP), an oncology company focused on the clinical development of novel therapies for cancer and Helsinn, a Swiss pharmaceutical group focused on …
MEI Pharma Inc (NASDAQ:MEIP) just received Breakthrough Therapy Designation for its key pipeline drug pracinostat, anti-tumor molecule inhibitor that combined with azacitidine treats …
MEI Pharma Inc (NASDAQ:MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced new clinical data from a …